Stomach Neoplasms
242
29
38
101
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
18 trials with published results (7%)
Research Maturity
101 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.4%
13 terminated out of 242 trials
88.6%
+2.0% vs benchmark
8%
19 trials in Phase 3/4
18%
18 of 101 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 101 completed trials
Clinical Trials (242)
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Conventional Versus Stomach-Partitioning Gastrojejunostomy for Malignant Gastric Outlet Obstruction in Stage IV Gastric Cancer (KLASS 16)
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)
A Phase IV Randomized Trial of Maxigesic® Versus Standard Analgesia After Radical Gastrectomy
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Default Option Nudging Intervention to Improve the Adherence Rates of Cancer Screening
Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer
One-Click Autofocus Versus Segmented Focus in Gastric Endoscopy
A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer
To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer
PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer
Single-port Versus Conventional Laparoscopic Surgery for Radical Proximal Gastric Cancer: A Randomized Controlled Trial
Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer